FDA Logo links to FDA home page
U.S. Food and Drug Administration
  HHS Logo links to Department of Health and Human Services website
 MedWatch logoThe FDA Safety Information and Adverse Event Reporting Program


line line line line line

Stay Informed
Subscribe to receive safety alerts
Get e-mail updates By email | MedWatch RSS [XML] Feed By RSS

What's New

Atrium Medical Corp Hydraglide Heparin-Coated Thoracic Drainage Catheters - [UPDATE] Recall of selected lots due to heparin contaminated with oversulfated chondroitin sulfate (OSCS).
(Posted 05/15/2008)

Heparin Coated Products - [UPDATE] Medtronic recalls selected heparin-coated products used during cardiopulmonary bypass surgery.
(Posted 05/15/2008)

Trasylol (aprotinin injection) [UPDATE 05/14/2008] - Bayer Pharmaceuticals notified the FDA of their intent to remove all remaining supplies of Trasylol from hospital pharmacies and warehouses.
(Posted 05/14/2008)

Cefepime (marketed as Maxipime) - [UPDATE] FDA continues its on-going analysis of safety data for cefepime.
(Posted 05/14/2008)

Heparin Sodium Injection - FDA requests that health professionals and facilities review and examine all drug/device storage areas to ensure that all recalled heparin products have been removed and are no longer available for patient use.
(Posted 05/09/2008)

Cardinal Alcohol-Free Mouthwash - Product recalled because of the presence of Burkholderia cepacia.
(Posted 05/06/2008)

May 2008 Patient Safety News - Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.
(Posted 05/06/2008)

Enbrel (etanercept) - Prescribing information revised to include a BOXED WARNING regarding the risk of infection including tuberculosis.
(Posted 05/01/2008)

Total Body Formula, Total Body Mega Formula - UPDATE: FDA analysis reveals high chromium levels in addition to selenium.
(Posted 05/01/2008)

Heparin Sodium Injection - Update to healthcare facilities and healthcare professionals about Heparin and Heparin-containing medical products.
(Posted 04/29/2008)

Digitek (digoxin tablets, USP) - Class I recall because tablets may contain twice the approved level of active ingredient.
(Posted 04/28/2008)

Welcome to MedWatch, your Internet gateway for timely safety information on drugs and other medical products regulated by the U.S. Food and Drug Administration.

 

Safety Information

Safety Information

 

Medical Product
Reporting

Medical Product Reporting

FDA MedWatch and Patient Safety
Video tutorial with optional quiz for healthcare professional students, healthcare providers, and their patients.

"FDA MedWatch and Patient Safety" video tutorial screenshot

 
horizonal rule